PIA
DCPH

Piedmont Investment Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Piedmont Investment Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-132
Closed -$5K – 2420
2018
Q2 		$5K Buy
+132
New +$3.88K ﹤0.01% 2163

Other funds holding DCPH

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Piedmont Investment Advisors's DCPH Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2018, closing a stake of 132 shares — an estimated $5K sold.

Piedmont Investment Advisors first reported a position in DCPH in Q2 2018 and held it in 1 quarter. The position peaked at $5K in Q2 2018. 88 funds tracked by Wall St. Rank hold DCPH as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 132 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $5K.
  • Piedmont Investment Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $5K in Q2 2018.
  • 88 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.